Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.17 CAD | -.--% | -.--% | +70.00% |
Business Summary
Number of employees: 1
Managers
Managers | Title | Age | Since |
---|---|---|---|
Timothy Ko
CEO | Chief Executive Officer | 39 | 19-06-30 |
Soo-Whan Kim
DFI | Director of Finance/CFO | - | 23-01-06 |
Andrew Hegle
BRD | Director/Board Member | 46 | 19-12-31 |
Joseph Cullen
IRC | Investor Relations Contact | 41 | 19-04-30 |
Kelly Pladson
SEC | Corporate Secretary | 42 | - |
Jonna Birgans
PRN | Corporate Officer/Principal | - | 21-02-03 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Timothy Ko
CEO | Chief Executive Officer | 39 | 19-06-30 |
Andrew Hegle
BRD | Director/Board Member | 46 | 19-12-31 |
Director/Board Member | 53 | 20-11-04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 8,858,934 | 8,668,934 ( 97.86 %) | 0 | 97.86 % |
Company contact information
Entheon Biomedical Corp.
999 West Broadway Suite 720
V5Z 1K5, Vancouver
+
http://www.entheonbiomedical.comSector
1st Jan change | Capi. | |
---|---|---|
+70.00% | 1.1M | |
+46.15% | 54.63B | |
-6.89% | 39.92B | |
+37.07% | 38.82B | |
+12.91% | 26.86B | |
-11.17% | 26.22B | |
-22.12% | 18.78B | |
+24.93% | 12.21B | |
+0.38% | 12.16B | |
+25.20% | 11.94B |
- Stock Market
- Equities
- ENBI Stock
- Company Entheon Biomedical Corp.